|Titre :||A national survey of marijuana use among US adults with medical conditions, 2016-2017 (2019)|
|Auteurs :||H. DAI ; K. P. RICHTER|
|Type de document :||Article : Périodique|
|Dans :||JAMA Network Open (Vol.2, n°9, September 2019)|
|Article en page(s) :||e1911936|
|Discipline :||EPI (Epidémiologie / Epidemiology)|
Thésaurus TOXIBASEADULTE ; CANNABIS ; USAGE THERAPEUTIQUE ; PREVALENCE ; SURVEILLANCE EPIDEMIOLOGIQUE ; COMPARAISON ; USAGE RECREATIF ; VOIE D'ADMINISTRATION ; GEOGRAPHIE ; PATHOLOGIE ; MOTIVATION
Importance: The number of states legalizing marijuana for medical and recreational use is increasing. Little is known regarding how or why adults with medical conditions use it.
Objectives: To report the prevalence and patterns of marijuana use among adults with and without medical conditions, overall and by sociodemographic group, and to further examine the associations between current marijuana use and the types and number of medical conditions.
Design, Setting, and Participants: This survey study used a probability sample of US adults aged 18 years and older from the 2016 and 2017 Behavioral Risk Factor Surveillance System, a telephone-administered survey that collects data from a representative sample of US adult residents across the states regarding health-related risk behaviors, chronic health conditions, and use of preventive services.
Main Outcomes and Measures: Current (past month) and daily (>=20 days in the last 30 days) marijuana use.
Results: The study sample included 169 036 participants (95 780 female [weighted percentage, 52.0%]). Adults with medical conditions had higher odds of reporting current marijuana use than those without medical conditions (age 18-34 years: adjusted odds ratio, 1.8 [95% CI, 1.5-2.1]; age 35-54 years: adjusted odds ratio, 1.4 [95% CI, 1.2-1.7]; age >=55 years: adjusted odds ratio, 1.6 [95% CI, 1.3-2.0]), especially among those with asthma, chronic obstructive pulmonary disease, arthritis, cancer, and depression. Among those with medical conditions, the prevalence of marijuana use decreased with increasing age, ranging from 25.2% (95% CI, 22.0%-28.3%) for those aged 18 to 24 years to 2.4% (95% CI, 2.0%-2.8%) for those aged 65 years or older for current marijuana use and from 11.2% (95% CI, 8.7%-13.6%) to 0.9% (95% CI, 0.7%-1.2%), respectively, for daily marijuana use. Most adults who used marijuana (77.5%; 95% CI, 74.7%-80.3%), either with or without medical conditions, reported smoking as their primary method of administration. Adults with medical conditions were more likely than those without medical conditions to report using marijuana for medical reasons (45.5% [95% CI, 41.1%-49.8%] vs 21.8% [95% CI, 17.8%-25.7%]; difference, 23.7% [95% CI, 17.8%-29.6%]) and less likely to report using marijuana for recreational purposes (36.2% [95% CI, 32.1%-40.3%] vs 57.7% [95% CI, 52.6%-62.9%]; difference, -21.5% [95% CI, -28.1% to 14.9%]).
Conclusions and Relevance: This study found that marijuana use was more common among adults with medical conditions than those without such conditions. Notably, 11.2% of young adults with medical conditions reported using marijuana on a daily basis. Clinicians should screen for marijuana use among patients, understand why and how patients are using marijuana, and work with patients to optimize outcomes and reduce marijuana-associated risks.
Question: What are the prevalence and patterns of marijuana use among adults with medical conditions?
Findings: This survey study using data from 169 036 participants in the 2016 and 2017 Behavioral Risk Factor Surveillance System surveys found that, compared with adults without medical conditions, adults with medical conditions had a significantly higher prevalence of current and daily marijuana use, were more likely to report using marijuana for medical reasons, and were less likely to report using marijuana for recreational purposes. Among respondents with medical conditions, 11.2% of young adults reported using marijuana on a daily basis, and the prevalence of marijuana use decreased with increasing age.
Meaning: Clinicians should discuss marijuana use with their patients to optimize medical outcomes.
|Domaine :||Drogues illicites / Illicit drugs|
|Refs biblio. :||24|
|Affiliation :||College of Public Health, University of Nebraska Medical Center, Omaha, USA|